Gong, C., Ma, G., Hu, X., Zhang, Y., Wang, Z., Zhang, J., . . . Wang, B. (2018). Pretreatment (18)F‐FDG Uptake Heterogeneity Predicts Treatment Outcome of First‐Line Chemotherapy in Patients with Metastatic Triple‐Negative Breast Cancer. Oncologist.
Chicago-tyylinen lähdeviittausGong, Chengcheng, et al. "Pretreatment (18)F‐FDG Uptake Heterogeneity Predicts Treatment Outcome of First‐Line Chemotherapy in Patients With Metastatic Triple‐Negative Breast Cancer." Oncologist 2018.
MLA-viiteGong, Chengcheng, et al. "Pretreatment (18)F‐FDG Uptake Heterogeneity Predicts Treatment Outcome of First‐Line Chemotherapy in Patients With Metastatic Triple‐Negative Breast Cancer." Oncologist 2018.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.